HealthCare Global Enterprises Ltd

HCG Expands into Africa with 10% Stake in Kenya’s Cancer Care Provider 🏥🌍

- HCG approves investment of up to 10% in Cancer Care Kenya Limited (CCK), a step-down subsidiary.

- Investment amount capped at INR 7 Crore, to be completed by March 31, 2026.

- CCK reported a turnover of INR 42.53 Crore and profit after tax of INR 10.83 Crore for FY 2024-25.

- HCG to issue Standby Letter of Credit (SBLC) for up to USD 1.8 million (~INR 16 Cr) to support CCK’s expansion.

- SBLC treated as contingent liability, released upon CCK’s full repayment.

- Transaction is arm’s length, no promoter involvement.

- No regulatory approvals needed for the acquisition.